{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:43:02Z","timestamp":1767854582971,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T00:00:00Z","timestamp":1298332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10067-011-1696-3","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T01:43:46Z","timestamp":1298252626000},"page":"955-957","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of IgA class antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease (IBD)"],"prefix":"10.1007","volume":"30","author":[{"given":"Hans-Jacob","family":"Haga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8yvind","family":"Palm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Peen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,22]]},"reference":[{"issue":"11","key":"1696_CR1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/rheumatology\/40.11.1256","volume":"40","author":"\u00d8 Palm","year":"2001","unstructured":"Palm \u00d8, Moum B, Jahnsen J, Gran JT (2001) The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatol (Oxford) 40(11):1256\u20131261","journal-title":"Rheumatol (Oxford)"},{"issue":"5","key":"1696_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","volume":"45","author":"AJ Zendman","year":"2006","unstructured":"Zendman AJ, van Venrooij WJ, Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatol (Oxford) 45(5):20\u201325","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"1696_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.autrev.2006.03.008","volume":"6","author":"WJ Venrooij van","year":"2006","unstructured":"van Venrooij WJ, Zendman AJ, Pruijn GJ (2006) Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 6(1):37\u201341","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1696_CR4","first-page":"253","volume":"26","author":"G Lakos","year":"2008","unstructured":"Lakos G, So\u00f3s L, Fekete A, Szab\u00f3 Z, Zeher M, Horv\u00e1th IF, Dank\u00f3 K, Kapit\u00e1ny A, Gyetvai A, Szegedi G, Szekanecz Z (2008) Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope. Clin Exp Rheumatol 26(2):253\u2013260","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1696_CR5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ibd.20038","volume":"13","author":"IE Koutroubakis","year":"2007","unstructured":"Koutroubakis IE, Karmiris K, Bourikas L, Kouroumalis EA, Drygiannakis I, Drygiannakis D (2007) Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations. Inflamm Bowel Dis 13(4):504\u2013505","journal-title":"Inflamm Bowel Dis"},{"key":"1696_CR6","first-page":"705","volume":"22","author":"K Papamichael","year":"2009","unstructured":"Papamichael K, Tsirogianni A, Papasteriades C, Mantzaris GJ (2009) Low prevalence of antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease regardless of the presence of arthritis. Eur J Gastroenterol Hepatol 22:705\u2013709","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1696_CR7","unstructured":"Gabriel SE. Classification of Rheumatic Diseases. In: Klippel JH, Dieppe P. Rheumatology. second ed, Vol. 1. London: Mosby 1998; 3.1\u20134."},{"issue":"4","key":"1696_CR8","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar2449","volume":"10","author":"A Kastbom","year":"2008","unstructured":"Kastbom A, Reckner-OlssonSv\u00e4rd AA, Skogh T (2008) Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Res Ther 10(4):R75, Epub 2008 Jul 4","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1696-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1696-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:48Z","timestamp":1559119908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1696-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,22]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1696-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,22]]}}}